International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.

Autoria(s): Schijman,AG; Bisio,M; Orellana,L; Sued,M; Duffy,T; Mejia Jaramillo,AM; Cura,C; Auter,F; Veron,V; Qvarnstrom,Y; Deborggraeve,S; Hijar,G; Zulantay,I; Lucero,RH; Velazquez,E; Tellez,T; Sanchez Leon,Z; Galvão,L; Nolder,D; Monje Rumi,M; Levi,JE; Ramirez,JD; Zorrilla,P; Flores,M; Jercic,MI; Crisante,G; Añez,N; De Castro,AM; Gonzalez,CI; Acosta Viana,K; Yachelini,P; Torrico,F; Robello,C; Diosque,P; Triana Chavez,O; Aznar,C; Russomando,G; Büscher,P; Assal,A; Guhl,F; Sosa Estani,S; DaSilva,A; Britto,C; Luquetti,A; Ladzins,J
Data(s)

01/01/2011
Resumo

A century after its discovery, Chagas disease still represents a major neglected tropical threat. Accurate diagnostics tools as well as surrogate markers of parasitological response to treatment are research priorities in the field. The purpose of this study was to evaluate the performance of PCR methods in detection of Trypanosoma cruzi DNA by an external quality evaluation.
Identificador

http://hdl.handle.net/10536/DRO/DU:30069783
Idioma(s)

eng
Publicador

PLoS
Relação

http://dro.deakin.edu.au/eserv/DU:30069783/orellana-internationalstudy-2011.pdf

http://www.dx.doi.org/10.1371/journal.pntd.0000931

http://www.ncbi.nlm.nih.gov/pubmed/21264349
Direitos

2011, PLoS
Tipo

Journal Article
Acesso ao item digital